Intervention: Palbociclib plus an aromatase inhibitor
Found 29 matching trials
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
N/A
A retrospective study of de-identified (to preserve patient privacy) patien...
Treatment Patterns and Clinical Outcomes Among Patients Receiving Palbociclib Combinations for Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2 ) Advanced/Metastatic Breast Cancer in the Arabian Gulf Region
N/A
retrospective non-interventional study (NIS) that aims to describe the demo...
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study
PHASE2
This phase II trial studies how well letrozole, anastrozole, or fulvestrant...